RxDoctor Payments Data

Maximillian Lincoln, MD

Adult Reconstructive Orthopaedic Surgery · Exeter, NHNPI 1710169891

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Zimmer Biomet accounts for 91.6% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $17,572 and has fallen 87.8% since, to $2,150 in 2025.

$36,283in general payments, 2019–2025

Across 163 payments — averaging $222.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$33K
  • Team 1, LLC$843
  • Encore Medical, LP$800
  • Stryker$672
  • Biocomposites Inc$179
  • Davol Inc.$176
  • plus $390 from 8 others
$15,060in research payments, 2019–2025

Across 8 payments — averaging $1882.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$15K

What the payments were for

  • Consulting fees$20,47556%
  • Travel & lodging$9,78027%
  • Food & beverage$5,22814%
  • Gifts$8002%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in New Hampshireto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$430,400
Medicare patients
870
Services billed
4,678

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine117$8,324
Meloxicam677$2,431
Diclofenac Sodium75$1,680
Tizanidine Hcl108$885
Celecoxib52$770
Gabapentin72$730
Methocarbamol37$349
Oxycodone Hcl13$92
Cefadroxil13$73
Amoxicillin49$60
Clindamycin Hcl27$40

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Exeter

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →